International Association for the Study of Lung Cancer (IASLC)-23rd World Conference on Lung Cancer (WCLC 2022) Abstracts

被引：0

作者：

Bandari, Roshini ^{[1
]}

机构：

[1] Clarivate, Hyderabad, Telangana, India

来源：

DRUGS OF THE FUTURE | 2022年 / 47卷 / 10期

关键词：

Sugemalimab; Avelumab; Datopotamab deruxtecan; Tarlatamab; QL-1206; JIN-A02;

D O I：

10.1358/dof.2022.47.10.3487259

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The World Conference on Lung Cancer (WCLC) is the world's largest meeting dedicated to lung cancer and other thoracic malignancies. In its 23rd edition, more than 7,000 delegates from 100+ countries came together to discuss the latest devel-opments in thoracic malignancy research. The meeting covered over 300 talks and 1,000+ poster presentations and 20 specialized tracks. This report covers a few of the presenta-tions discussing treatments for lung cancers.

引用

页码：767 / 769

页数：3